Top 5 Cosmetic Plastic Minimally Invasive Procedures in 2009
Cosmetic minimally-invasive procedures increased 1 percent, to nearly 11 million procedures in 2009 according to statistics released by the American Society of Plastic Surgeons. Minimally-invasive procedures are up 99 percent since 2000. The top five minimally-invasive procedures in 2009 were:
* Botulinum toxin type A (4.8 million)
* Soft tissue fillers (1.7 million)
* Chemical peel (1.1 million)
* Microdermabrasion (910,000)
* Laser hair removal (893,000)
“Skin is in,” said Dr. McGuire. “Chemical peels and soft tissue fillers like hyaluronic acid are up 9 percent, microdermabrasion is up 8 percent – these are the procedures that patients are opting for despite the economy.”
“It would seem, as innovations in cosmetic minimally-invasive procedures increase, surgery will continue to decrease,” added Dr. McGuire. “However, as the economy rebounds, more patients and Boomers will continue to seek surgical body contouring procedures (liposuction, tummy tuck), eyelid surgery and breast augmentations. In fact, breast augmentations are up 36 percent since 2000. Silicone implants are now used in 50 percent of all breast augmentations.”
Although it’s been a sluggish year for plastic surgery due to the economy the long-term outlook is more encouraging. According to statistics released by the American Society of Plastic Surgeons (ASPS), 12.5 million cosmetic plastic surgery procedures were performed in the United States in 2009.
Cosmetic surgical procedures decreased 9 percent, with more than 1.5 million procedures in 2009. Surgical procedures are down 20 percent since 2000. The top five surgical procedures in 2009 were:
FDA Approves First Sclerosant to Treat Small Varicose Veins in 60 Years
Washington – Merz Aesthetics makes its debut at the prestigious American Society of Aesthetic Plastic Surgeons (ASAPS) annual meeting with the announcement of the U.S. Food and Drug Administration’s (FDA) recent approval of Asclera™ (polidocanol) Injection, a sclerotherapy treatment for uncompplicated spider and reticular veins.
“Spider and reticular veins are a common, often embarrassing condition that can be treated safely and effectively,” said Robert A. Weiss, M.D., director of the Maryland Laser, Skin, and Vein Institute and Associate Professor of Dermatology at Johns Hopkins University School of Medicine in Baltimore, MD. “Asclera™ is a minimally-invasive option for patients who are unhappy with the appearance of their legs.”
The FDA approved Asclera™ (polidocanol) Injection on March 30, 2010 to sclerose uncomplicated spider veins (varicose veins less than or equal to 1 mm in diameter) and uncomplicated reticular veins (varicose veins 1 to 3 mm in diameter) in the lower extremity, making it the first sclerosant to be approved in over 60 years. Once injected, Asclera™ acts by damaging the cell lining of blood vessels, causing them to close and eventually be replaced by other types of tissue. Asclera™ is safe and effective when used as directed. Commonly observed local adverse events included injection site hematoma, irritation, and discoloration. Asclera™ has not been studied in varicose veins more than 3 mm in diameter.
“We are very excited about the approval of this treatment, expanding our aesthetics portfolio with products that really matter to patients,” said Dennis Condon, President of BioForm Medical, Inc., a Merz Aesthetics company. “Merz Aesthetics is committed to bringing forward true innovation to solve real problems that impact the lives of aesthetics users, and this takes us in the right direction.”
During the meeting, the company will also unveil the first phase of a unique national consumer survey of women’s experiences and perceptions of minimally-invasive cosmetic procedures. The results shed some light on the underlying motivations behind these women’s cosmetic procedure choices.
- Un equipo español realiza el primer trasplante total de cara en todo el mundo
- 30 profesionales médicos trabajaron en la operación durante 22 horas
El Hospital Vall d’Hebron, en Barcelona, ha informado esta mañana sobre los detalles del primer trasplante total de cara del mundo, que fue realizado el pasado 20 de marzo por 30 profesionales que se emplearon durante 22 horas. Los 11 anteriores trasplantes (Francia, Sevilla, Valencia, Estados Unidos y China) habían sido parciales.
El receptor del primer trasplante total de cara del mundo -cuya identidad no ha sido desvelada para preservar su intimidad- es un hombre joven que sufría deformidad severa en el rostro causada por un traumatismo. Esa deformidad le impedía respirar por la nariz y la boca, a la vez que le producía una gran dificultad para deglutir y hablar.
- Baby boomers keep cosmetic procedures on the rise
- Facelifts, eyelid lifts among anti-aging surgeries up in 2009
Chicago – The baby boomer generation may be well into their 50s and 60s, but that doesn’t mean they’re ready to concede their looks just yet. In fact, many “boomers” are determined to maintain their once-youthful appearance.
According to a recent survey by the American Academy of Cosmetic Surgery, anti-aging procedures such as facelifts and blepharoplasty (eyelid lifts) are on the rise. So are botox and fillers. The bottom line is that baby boomers are aging but they don’t want their looks to do the same.
Before and after blepharoplasty
“The baby boomers are getting older but they still feel young and they want to look that way too,” said AACS President Mark Berman, MD. “With anti-aging procedures, people tend to feel much better about themselves afterward.”
Facelifts rose 44 percent from 2008 to 2009 in procedures by AACS members, totaling 34,455 in ’09. Blepharoplasty procedures went up 42 percent, from 42,602 to 60,507. Similarly, non-invasive anti-aging procedures such as Botox (up 157 percent) and fillers (up 245 percent) rose exponentially.
In procedures performed by AACS members, the average age of facelift patients is 54.1 years. The average age for blepharoplasty is 52.3 years. In addition, the average age of patients receiving Botox is 46.6 and fillers is 46.8.
“I think this might come as a surprise to the public when they see just how many baby boomers are trying to slow down the aging process,” Berman said. “As a surgeon, these numbers aren’t surprising because we see older patients all the time.”
Source: American Academy of Cosmetic Surgery
For more information about plastic surgery procedures don’t hesitate to contact Sublimis – Medical Tourism.
Belief that intentional weight loss is harmful to seniors is unfounded
Winston-Salem, NC – A new study by researchers at Wake Forest University Baptist Medical Center is the first to refute the widely held belief that intentional weight loss in older adults leads to increased risk of death.
In fact, the research shows that seniors who intentionally exercised and/or modified their diets to lose weight were half as likely to die within eight years of follow-up as their peers who did not work toward weight loss, said M. Kyla Shea, Ph.D., first author on the study and a research associate in the Department of Internal Medicine, Section on Gerontology and Geriatric Medicine.
“It was an unusually strong and surprising finding,” Shea said. “Our data suggest that people should not be concerned about trying or recommending weight loss to address obesity-related health problems in older adults.”
The study, funded by the National Institute on Aging, is currently available online and is schedule to appear in a future print issue of the Journal of Gerontology: Medical Sciences.
Prior to this study, research that has looked at the association between mortality and weight loss has not factored in the many different potential causes of the weight loss. So, using a more rigorous randomized trial approach, Shea and colleagues sought to prove or disprove the idea that older individuals who actively tried to lose weight increased their risk of death.
New Study May Explain How Weight-loss Surgery Reverses Type 2 Diabetes
California – A team of researchers, led by a UC Davis veterinary endocrinologist, has shown for the first time that a surgical procedure in rats that is similar to bariatric surgery in humans can delay the onset of type 2 diabetes. The researchers also have identified biochemical changes caused by the surgeries that may be responsible for that delay.
Findings from the study, published online in the journal Gastroenterology, should help researchers identify strategies for preventing and treating type 2 diabetes, a chronic condition in which the body is unable to properly metabolize sugar and fat, leading to serious complications including heart disease, blindness and kidney failure.
Type 2 diabetes affects more than 21 million people in the United States, where it results in more than $150 billion in direct and indirect annual costs, according to the National Institutes of Health.
“Bariatric surgery currently is considered to be the most effective long-term treatment for human obesity and often leads to marked improvements in diabetes,” said the study’s lead author Peter Havel, a professor with joint appointments in the School of Veterinary Medicine and Department of Nutrition.
“It has been thought that reduction of blood sugar, which indicates a reversal of type 2 diabetes, in patients following bariatric surgery was due to post-surgery weight loss,” Havel said. “This study, however, supports the observations from a number of earlier clinical studies reporting that diabetes is often improved prior to substantial weight loss. It also suggests that endocrine changes in hormones produced by the gastrointestinal tract may contribute to the early effects of bariatric surgery, in addition to the later effects of weight loss.”
“This study confirms our clinical observations that metabolic regulation — specifically homeostasis of glucose — occurs quickly after gastric bypass surgery,” said Mohamed Ali, an associate professor of gastrointestinal surgery and a specialist in bariatric surgery at UC Davis Health System. “It’s clear from the outcome that something physiologic is at work with controlling diabetes that is not related to weight loss.
More than 17 million cosmetic procedures performed last year in USA
Chicago – A procedural survey conducted by the American Academy of Cosmetic Surgery says more than 17 million cosmetic surgery procedures were performed in the United States in 2009.
The total number of procedures from this first-time study far surpasses any number that has previously been reported in the U.S. This is the first nationwide survey of its kind done by the AACS. In addition to the annual polling of its own members, the AACS also surveyed random physicians across the country to find out who is performing cosmetic surgery procedures.
The total number of procedures performed by AACS members has increased by eight percent since 2008.
“The cosmetic surgery industry continues to grow at a rate many people never thought it would reach,” said AACS President Mark Berman, MD. “With the aging of the baby boomer generation, I don’t think we’ve come close to hitting the ceiling yet. That 17 million is only going to expand.”
Among AACS member practices, the biggest increase in invasive procedures in the last five years are in blepharoplasty (eyelid lift), abdominoplasty (tummy tuck) and rhinoplasty (nose). For less-invasive procedures, the biggest increase over that five-year period is in laser resurfacing, chemical peels and fillers.
Before and After a Tummy Tuck Procedure
For AACS members, rhinoplasty surgeries jumped from 12,460 in 2008 to 21,730 in 2009, a 74 percent increase. Facelifts were also up this year, from 20,478 in ’08 to 34,455 in ’09, a 44 percent spike.
“As the economy recovers slowly but surely, we are seeing patients come back and feel better about doing some things for themselves that maybe they’d been putting off for a while,” Berman said.
Entries (RSS)